PHARMACY AND PHARMACOLOGY JOURNAL
Qingdi Quentin Li
Designation: Research Scientist
Department: Urologic Oncology
University: National Institutes of Health
Country: United States
Q. Quentin Li is a research scientist at the National Institutes of Health, and was an assistant professor at the Mary Babb Randolph Cancer Center, West Virginia University Robert C. Byrd Health Sciences Center. He was a guest (visiting) professor for six reputed universities in China. He obtained an M.D. from China and worked as dermatologist at Sun Yat-Sen University School of Medicine. He also received his M.S. in microbiology & immunology and Ph.D. in pharmacology & experimental therapeutics from the University of Maryland School of Medicine, with postdoctoral training in molecular and cell biology of cancer in Medical Oncology Branch (formerly Medicine Branch) of the Center for Cancer Research at the National Cancer Institute. He is a member of the American Association for Cancer Research. He served as principal investigator on several grants funded by the National Institutes of Health and a pharmaceutical company. He was elected to Who’s Who in Medicine & Healthcare, Who’s Who in Science & Engineering, Who’s Who in America, and Who’s Who in the World in 2002 and 2003.
Cellular metabolism, Cancer epigenetics, Cancer chemotherapy & epigenetic therapy, Molecular and cell biology of cancer, Photoimmunotherapy, Oncopharmacology, New antitumor drug research & development, Natural products as novel anticancer agents, Apoptosis & cell cycle control in cancer cells, DNA repair and platinum drug resistance in carcinomas, Identification of biomarkers & epigenetic markers for diagnosis & treatment of carcinomas, Epigenetic regulation of gene expression in T cells & tumor cells.
Open Access Journals
Subscribe to our Newsletter
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: email@example.com
Recently Released Issues
Copyright © 2020 Boffin Access Limited.